[Renal failure and hemolytic anemia. Rifampicin associated interstitial nephropathy with immune hemolytic anemia].
Bodmer
M
M
Abteilung für klinische Pharmakologie und Toxikologie, Universitätsspital Basel, Hebelstrasse 2, Basel. mliechtr@uhbs.ch
Haschke
M
M
Rätz Bravo
A E
AE
Liechti
M E
ME
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000175:diagnosis; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000175:diagnosis; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D009395:Nephritis, Interstitial / Q000139:chemically induced* / Q000175:diagnosis; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D012293:Rifampin